Thrombopoietin: Clinical Trials

12 trials of Thrombopoietin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown, 2 completed, 2 recruiting, 1 terminated. 12 Phase 2, 4 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 212Unknown 7, Completed 2, Recruiting 2, Terminated 1
Phase 34Unknown 3, Terminated 1
Phase 13Completed 2, Unknown 1

Follow Thrombopoietin: new trials by email Literature Review of Thrombopoietin trials Research Report on Thrombopoietin

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA
Romiplostim, Recombinant Human Thrombopoietin - MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA)
Phase 2RecruitingThe First Affiliated Hospital of Soochow University662026-01-312026-04-15
Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery
Lusutrombopag combined with recombinant human thrombopoietin - Thrombocytopenia
Phase 2RecruitingAnhui Provincial Hospital602024-11-102024-11-05
IVIg Plus Low Dose rhTPO for ITP in Pregnancy
intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO), intravenous immunoglobulin - Immune Thrombocytopenia, Pregnancy Related
Phase 2UnknownPeking University People's Hospital502023-01-012022-12-02
The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy
Prednisone, Recombinant Human TPO - Immune Thrombocytopenia
Phase 2UnknownPeking University People's Hospital902021-06-012022-04-19
A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia
Danazol + rhTPO (recombinant human thrombopoietin injection), Danazol + sodium chloride - Low/Intermediate Risk-1 MDS
Phase 2 / Phase 3UnknownPeking Union Medical College Hospital752020-03-012020-03-27
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia
rhTPO, Placebo - Sepsis, Thrombocytopenia
Phase 2 / Phase 3UnknownRuilan Wang2002019-04-012024-04-18
Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
rhTPO, placebo - Anemia, Aplastic
Phase 2UnknownTianjin Medical University General Hospital2502016-08-012016-08-05
Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation
Recombinant Human Thrombopoietin - Thrombocytopoietin, Hematopoietic Stem Cell Mobilization
Phase 1 / Phase 2UnknownHongnan Mo502016-06-012019-12-06
Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
MPs, thrombopoietin (TPO) and interleukin-11 - Hematological Diseases, Thrombocytopenia
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University2502014-09-012014-09-16
Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
recombinant human thrombopoietin - Carcinoma, Non-Small-Cell Lung
Phase 2 / Phase 3TerminatedChinese Society of Lung Cancer112011-02-012017-03-03
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy
Recombinant Human Thrombopoietin - Germ Cell Tumors, Hepatic Cancer
Phase 1 / Phase 2CompletedSt. Jude Children's Research Hospital402000-06-012008-04-10
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
filgrastim, recombinant flt3 ligand, recombinant human thrombopoietin - Breast Cancer, Leukemia
Phase 1 / Phase 2CompletedNorthwestern University1999-11-012012-06-06

Conditions studied

Thrombocytopenia (4)  ·  Anemia, Aplastic (2)  ·  Purpura, Thrombocytopenic, Idiopathic (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Hematologic Diseases (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Intraocular Lymphoma (1)  ·  Jacobs syndrome (1)  ·  Leukemia (1)  ·  Leukemia, Biphenotypic, Acute (1)

Sponsors

Peking University People's Hospital (2)  ·  Anhui Provincial Hospital (1)  ·  Chinese Society of Lung Cancer (1)  ·  Hongnan Mo (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  Northwestern University (1)  ·  Peking Union Medical College Hospital (1)  ·  Ruilan Wang (1)  ·  St. Jude Children's Research Hospital (1)  ·  The First Affiliated Hospital of Soochow University (1)  ·  Tianjin Medical University General Hospital (1)

Countries

China (9)  ·  United States (2)

Top investigators

Jane N. Winter, MD (1)  ·  Lianxin Liu (1)  ·  Najat C. Daw, M.D. (1)  ·  Qifa Liu, MD (1)  ·  Ruilan Wang, MD,PhD (1)  ·  Xiao-hui Zhang, Professor (1)  ·  Yi-Long Wu, Professor (1)

Results publications

PMID 19117511, PMID 31492102, PMID 34505019, PMID 34778037